Skip to main content
Premium Trial:

Request an Annual Quote

Icoria Unit to Sell miRNA Arrays Made by Rosetta Genomics

NEW YORK, Oct. 15 (GenomeWeb News) - A unit of Icoria will exclusively sell Rosetta Genomics' MirChip microRNA detection and analysis services, the companies said today.


Icoria's Paradigm Array Labs business unit will commercialize the service, which will be launched Oct. 26 at the American Society of Human Genetics conference in Toronto, the firms said.

Financial details of the deal were not disclosed.

Icoria, which used to be Paradigm Genetics, is an authorized service provider for Affymetrix and Agilent gene expression-analysis platforms.


Rosetta Genomics is based in Rehovot, Israel.

The Scan

Positive Framing of Genetic Studies Can Spark Mistrust Among Underrepresented Groups

Researchers in Human Genetics and Genomics Advances report that how researchers describe genomic studies may alienate potential participants.

Small Study of Gene Editing to Treat Sickle Cell Disease

In a Novartis-sponsored study in the New England Journal of Medicine, researchers found that a CRISPR-Cas9-based treatment targeting promoters of genes encoding fetal hemoglobin could reduce disease symptoms.

Gut Microbiome Changes Appear in Infants Before They Develop Eczema, Study Finds

Researchers report in mSystems that infants experienced an enrichment in Clostridium sensu stricto 1 and Finegoldia and a depletion of Bacteroides before developing eczema.

Acute Myeloid Leukemia Treatment Specificity Enhanced With Stem Cell Editing

A study in Nature suggests epitope editing in donor stem cells prior to bone marrow transplants can stave off toxicity when targeting acute myeloid leukemia with immunotherapy.